The deregulation of 48 over-the-counter (OTC) drugs as “quasi-drugs,” is seen as a much needed move for the domestic industry, but not everyone is going to benefit from it.
With a wider sales platform, pharmaceutical companies, many of which saw their sales fall following a government crackdown on kickbacks given to doctors or pharmacies, expect a rebound, but only a few will gain an advanta...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.